​

Ionis Pharmaceuticals Ownership | Who Owns Ionis Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Ionis Pharmaceuticals Ownership Summary


Ionis Pharmaceuticals is owned by 106.57% institutional investors, 0.70% insiders. Dld asset management, lp is the largest institutional shareholder, holding 15.71% of IONS shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.76% of its assets in Ionis Pharmaceuticals shares.

IONS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockIonis Pharmaceuticals106.57%0.70%-7.27%
SectorHealthcare Stocks 129.28%12.06%-41.34%
IndustryBiotech Stocks 181.42%11.67%-93.09%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Dld asset management, lp25.00M15.71%$34.63B
Fmr24.74M14.96%$1.10B
Capital world investors21.79M13.17%$972.80M
Vanguard group16.44M10.23%$1.30B
Blackrock funding, inc. /de13.19M7.98%$589.06M
Blackrock10.32M7.09%$491.90M
Vanguard portfolio management7.72M4.67%$344.67M
Wellington management group llp7.65M4.64%$606.68M
Vanguard capital management7.22M4.36%$322.31M
Lombard odier asset management (europe)6.49M4.08%$8.96M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Boone capital management519.98K9.64%$41.23M
Davern capital partners, lp1.09M9.44%$48.54M
Tweedy, browne1.79M6.52%$80.08M
Jones hill capital lp599.83K4.55%$26.78M
Exome asset management88.18K4.31%$6.99M
Vestal point capital, lp1.07M3.18%$70.33M
Sector gamma as330.04K3.04%$14.74M
Privium fund management b.v.349.00K3.02%$15.58M
Eversept partners, lp664.68K2.73%$52.70M
Orion investment220.78K2.61%$9.86M

Top Buyers

HolderShares% AssetsChange
Dld asset management, lp25.00M2.48%25.00M
Lombard odier asset management (europe)6.49M0.45%6.49M
Blackrock funding, inc. /de13.19M0.01%2.49M
Westfield capital management co lp2.40M0.35%2.40M
Royal bank of canada6.18M0.07%2.38M

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---2.54M
Artisan partners limited partnership278.30K0.02%-2.36M
T. rowe price investment management3.96M0.21%-2.20M
Bvf inc/il---1.91M
Jpmorgan chase975.89K0.00%-1.70M

New Positions

HolderShares% AssetsChangeValue
Dld asset management, lp25.00M2.48%25.00M$34.63B
Lombard odier asset management (europe)6.49M0.45%6.49M$8.96M
Balyasny asset management768.65K0.05%768.65K$30.37M
Jones hill capital lp599.83K4.55%599.83K$26.78M
Global alpha capital management436.79K1.27%436.79K$19.50M

Sold Out

HolderChange
Medallion wealth advisors-1.00
Activest wealth management-1.00
Plante moran financial advisors-2.00
Dunhill financial-2.00
Wealth enhancement trust services-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2026499-10.73%176,288,641-2.80%1060.89%235-15.77%1656.45%
Jun 30, 20265494.77%181,160,5464.97%1090.94%2758.27%151-1.95%
Mar 31, 2026320-39.16%77,385,968-54.54%480.43%144-47.83%98-32.41%
Dec 31, 2025388-18.32%92,594,267-53.74%570.36%211-18.53%100-14.53%
Sep 30, 202544917.23%194,303,01714.72%1221.08%24117.56%1156.48%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S11.23M6.76%78.82K
Fidelity Growth Compy Commingled Pl O9.71M6.16%90.97K
Fidelity Growth Company Fund8.50M5.12%400.00
American Funds Growth Fund of Amer A7.67M4.64%1.27M
Capital Group Growth Fnd of Amer Comp7.67M4.61%-
American Funds Growth Fd of Amer A7.67M4.61%-
BB Biotech AG Ord6.22M3.84%-1.63M
Vanguard Total Stock Mkt Idx Inv4.99M3.02%-9.79K
Vanguard MStar Total Stk Mkt Idx Invest5.01M3.02%14.52K
Vanguard Morn Total Stk Mkt Idx Investor4.99M3.00%-9.79K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 10, 2026Hayden Michael R-Buy$148.20K
Oct 16, 2026Devers Shannon L. EVP, Chief Human Resources OfcSell$59.08K
Oct 16, 2026Swayze Eric EVP ResearchSell$2.31K
Jul 31, 2026Hayden Michael R-Buy$258.00K
Jul 30, 2026Hayden Michael R-Buy$800.70K

Insider Transactions Trends


DateBuySell
2026 Q326
2026 Q2-26
2026 Q1-54
2025 Q4-33
2025 Q3-40

IONS Ownership FAQ


Who Owns Ionis Pharmaceuticals?

Ionis Pharmaceuticals shareholders are primarily institutional investors at 106.57%, followed by 0.70% insiders and -7.27% retail investors. The average institutional ownership in Ionis Pharmaceuticals's industry, Biotech Stocks , is 181.42%, which Ionis Pharmaceuticals falls below.

Who owns the most shares of Ionis Pharmaceuticals?

Ionis Pharmaceuticals’s largest shareholders are Dld asset management, lp (25M shares, 15.71%), Fmr (24.74M shares, 14.96%), and Capital world investors (21.79M shares, 13.17%). Together, they hold 43.84% of Ionis Pharmaceuticals’s total shares outstanding.

Does Blackrock own Ionis Pharmaceuticals?

Yes, BlackRock owns 7.09% of Ionis Pharmaceuticals, totaling 10.32M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 491.9M$. In the last quarter, BlackRock increased its holdings by 549.14K shares, a 5.62% change.

Who is Ionis Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Boone capital management is Ionis Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 9.64% of its assets in 519.98K Ionis Pharmaceuticals shares, valued at 41.23M$.

Who is the top mutual fund holder of Ionis Pharmaceuticals shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Ionis Pharmaceuticals shares, with 6.76% of its total shares outstanding invested in 11.23M Ionis Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools